rdoe_global.search

N1-Methyl-Pseudo-UTP, GMP Grade, AOF

sodium salt, 100 mM, solution

A clean start in mRNA synthesis

Modified ribonucleotides enhance the expression and reduce the immunogenicity of mRNA. They are key to the success of therapeutic or vaccine mRNA.

Partially or completely replace UTP with this modified UTP to enhance the performance of modified mRNA. A fit-for-purpose reagent to manufacture mRNA for therapeutics and vaccines, Roche CustomBiotech N1-Methyl-Pseudo-UTP provides the performance, quality, and scale you need.

 

We have designed our manufacturing process from the master cell bank to final QC-release to exclude or minimize potential contaminants, thereby reducing overall process risk and simplifying procedures for regulatory approval.

Produced using validated manufacturing and cleaning processes up to the final filling step and released under stringent final QC checks. Know that you are getting consistent quality every time.

from the generation of the master cell bank to the final filling, noanimal-derived materials are used in the process. This greatly simplifies your risk analysis.

The enzymes used in the synthesis process have been made without the use of ß-lactam antibiotics. Therefore, allergic reactions to antibiotics is not a factor in your overall risk analysis.

tested during final QC-release for the absence of impurities such as nucleases, host-cell DNA and protein, bioburden, heavy metals, or endotoxins. Work with an enzyme at peak performance that poses no risk to downstream processing.

We work with you to provide the necessary technical documents for your regulatory submissions.

Changing reagent quality between pre-clinical development and commercialization poses a risk. Secure your processes by using the best available quality from the start.

Related pages

Downloads

Contact Us

Ordering Information

Technical documents

for certificates, method sheets (instructions for use), safety data sheets and software downloads
ACCESS ROCHE PORTAL ELABDOC artboard
Pseudo-UTP, AOF
Pseudo-UTP, AOF sodium salt, 100 mM, solution Partially or completely replace UTP with this modified UTP to enhance the performance of modified mRNA - a fit-for-purpose reagent to manufacture mRNA for therapeutics and vaccines.
DNase I, rec., GMP Grade, AOF
DNase I, rec., GMP Grade, AOF from bovine pancreas, recombinant, expressed in Pichia pastoris, solution DNase I is an essential enzyme for efficient digestion of DNA during RNA purification. For any sensitive RNA-based application, the quality of input RNA matters. Discover how this fit-for-purpose reagent meets your needs.
SP6 RNA Polymerase, rec., GMP Grade, AOF
SP6 RNA Polymerase, rec., GMP Grade, AOF from SP6 bacteriophage, recombinant in E.coli, solution SP6 RNA Polymerase transcribes RNA from double-stranded DNA templates that are downstream from an SP6 promoter. Discover this fit-for-purpose enzyme for manufacturing of mRNA therapeutics.
cb
RNase Inhibitor, rec., GMP Grade, AOF from rat lung, expressed in E. coli, solution Protect (m)RNA: RNase Inhibitor is essential whenever RNA needs protection from ubiquitous RNases. Discover this fit-for-purpose reagent to manufacture mRNA for therapeutics and vaccines.
cb
Restriction endonuclease Xba I, recombinant, AOF from Xanthomonas campestris pv. Badrii, expressed in E. coli, solution High quality template for mRNA synthesis. Antibiotic-free and Animal-Origin-Free (AOF). Discover the quality, scale and performance to manufacture templates for mRNA therapeutics and vaccines.
pyrophosphatase
Pyrophosphatase, rec., GMP Grade, AOF from yeast, expressed in E. coli, solution Improve your yield of mRNA with this essential enzyme for in vitro transcription of mRNA. By hydrolyzing inorganic pyrophosphate, it shifts the equilibrium of the mRNA synthesis reaction towards the formation of mRNA. Discover this fit-for-purpose reagent.
logo
T7 RNA Polymerase, rec., GMP Grade, AOF from T7 bacteriophage, recombinant in E.coli, solution T7 RNA Polymerase is the key enzyme for in vitro transcription of mRNA. Discover this fit-for-purpose enzyme for the synthesis of mRNA for therapeutics or vaccines.
ATP, GMP Grade, AOF
ATP, GMP Grade, AOF 100 mM, pH 8.3 ATP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.
CTP, GMP Grade, AOF
CTP, GMP Grade, AOF 325 mM, pH 8.3 CTP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.In contrast to the standard concentration of 100 mM, the higher concentrated 325 mM soltution, allows you a higher degree of freedom in the setup of you IVT-conditions.
CTP, GMP Grade, AOF
CTP, GMP Grade, AOF 100 mM, pH 8.3 CTP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.
GTP, GMP Grade, AOF
GTP, GMP Grade, AOF 325 mM, pH 8.3 GTP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.In contrast to the standard concentration of 100 mM, the higher concentrated 325 mM soltution, allows you a higher degree of freedom in the setup of you IVT-conditions.
GTP, GMP Grade, AOF
GTP, GMP Grade, AOF 100 mM, pH 8.3 GTP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.
ATP, GMP Grade, AOF
ATP, GMP Grade, AOF 325 mM, pH 8.3 ATP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.In contrast to the standard concentration of 100 mM, the higher concentrated 325 mM soltution, allows you a higher degree of freedom in the setup of you IVT-conditions.
UTP, GMP Grade, AOF
UTP, GMP Grade, AOF 100 mM, pH 8.3 UTP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.
UTP, GMP Grade, AOF
UTP, GMP Grade, AOF 325 mM, pH 8.3 UTP is produced using a sustainable, non-chemical process. In contrast to a chemical synthesis, this process avoids heavy metal catalysed processes. The production is completely animal origin free. To comply with regulatory requirements, it produced under GMP The manufacturing process is validated including the final filling step, followed by QC-release testing. The pH is adjusted to match conditions for in vitro transcription. To ensures you a stable pH during shipment on dry ice and constant product quality, the solution is supplied in sealed and CO2-proof bottles.In contrast to the standard concentration of 100 mM, the higher concentrated 325 mM soltution, allows you a higher degree of freedom in the setup of you IVT-conditions.
logo
Proteinase K, rec., PCR Grade, sol. from Titrirachium album, expressed in Pichia pastoris, solution Proven performance in diagnostics and pharma: For DNA or (m)RNA isolation, Proteinase K is the enzyme of choice to remove proteins that are still present adjacent to the nucleic acids. Discover CustomBiotech's Proteinase K.
error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later